Pharmacokinetics of radioimmunotherapeutic agent of direct labeling mAb (188)Re-HAb18

AIM: To label anti-hepatoma monoclonal antibody (mAb) fragment HAb18 F(ab’)(2) was labeled with (188)Re for the pharmacokinetic model of (188)Re-HAb18 F(ab’)(2) and to evaluate its pharmacokinetic parameters in hepatoma-bearing nude mice. METHODS: HAb18 F(ab’)(2) was directly labeled with (188)Re us...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Lou, Chao, Chen, Zhi-Nan, Bian, Hui-Jie, Li, Jie, Zhou, Shou-Bo
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2002
Assuntos:
Liver Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4656629/
https://ncbi.nlm.nih.gov/pubmed/11833074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v8.i1.69
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados